Jubilant Ingrevia has received Establishment Inspection report (EIR) from United States Food and Drug Administration (USFDA) with Zero 483 inspectional observations for the inspection performed in the month of April, 2024 at Manufacturing facility, Unit -1 located at Bharuch, Gujarat, India.
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company’s strategic capex initiative, shall position Jubilant Ingrevia further to capitalize and mark company’s foray into regulated market to cater the growing business requirements in the Nutraceuticals, Dietary Active Ingredients, Cosmetic Grade Applications – Active Ingredients, Drug Intermediates, CDMO products intended for industry application and human consumption.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
| Company Name | CMP |
|---|---|
| BASF India | 3640.10 |
| Tata Chemicals | 809.45 |
| SRF | 2519.20 |
| Pidilite Inds. | 1375.55 |
| Deepak Nitrite | 1736.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: